• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis".

作者信息

Gutierrez-Arias Ruvistay, Oliveros Maria-Jose, Seron Pamela

机构信息

Servicio de Medicina Física y Rehabilitación, Unidad de Kinesiología, Instituto Nacional del Tórax, Santiago, Chile.

Exercise and Rehabilitation Sciences Laboratory, Faculty of Rehabilitation Sciences, School of Physical Therapy, Universidad Andres Bello, Santiago, Chile.

出版信息

Can J Respir Ther. 2023 Apr 11;59:100-102. doi: 10.29390/cjrt-2023-013. eCollection 2023.

DOI:10.29390/cjrt-2023-013
PMID:37056576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10089679/
Abstract
摘要

相似文献

1
Comment on "Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis".关于“高渗盐水与等渗盐水对囊性纤维化儿童的疗效：系统评价与荟萃分析”的评论
Can J Respir Ther. 2023 Apr 11;59:100-102. doi: 10.29390/cjrt-2023-013. eCollection 2023.
2
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.吸入高渗盐水对 3-6 岁囊性纤维化儿童肺部结构的影响（SHIP-CT）：一项多中心、随机、双盲、对照试验。
Lancet Respir Med. 2022 Jul;10(7):669-678. doi: 10.1016/S2213-2600(21)00546-4. Epub 2022 Mar 11.
3
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.吸入高渗盐水治疗囊性纤维化学龄前儿童（SHIP）：一项多中心、随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2019 Sep;7(9):802-809. doi: 10.1016/S2213-2600(19)30187-0. Epub 2019 Jun 6.
4
Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis.高渗盐水与等渗盐水对囊性纤维化儿童的疗效：一项系统评价与荟萃分析。
Can J Respir Ther. 2023 Jan 20;59:1-7. doi: 10.29390/cjrt-2022-046. eCollection 2023.
5
Nebulised hypertonic saline for cystic fibrosis.雾化高渗盐水用于囊性纤维化
Cochrane Database Syst Rev. 2000(2):CD001506. doi: 10.1002/14651858.CD001506.
6
The efficacy of inhaled hypertonic saline for bronchiectasis: a meta-analysis of randomized controlled studies.吸入高渗盐水治疗支气管扩张症的疗效：一项随机对照研究的荟萃分析。
Am J Emerg Med. 2020 Dec;38(12):2713-2717. doi: 10.1016/j.ajem.2020.08.042. Epub 2020 Aug 17.
7
Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.吸入高渗盐水在婴儿和 6 岁以下囊性纤维化儿童中的应用：ISIS 随机对照试验。
JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.
8
The effectiveness of prehospital hypertonic saline for hypotensive trauma patients: a systematic review and meta-analysis.院前高渗盐水对低血压创伤患者的有效性：一项系统评价和荟萃分析。
BMC Emerg Med. 2017 Nov 28;17(1):35. doi: 10.1186/s12873-017-0146-1.
9
Efficacy and safety of hypertonic saline solutions fluid resuscitation on hypovolemic shock: A systematic review and meta-analysis of randomized controlled trials.高渗盐水溶液复苏治疗低血容量性休克的疗效和安全性：系统评价和随机对照试验的荟萃分析。
Cardiol J. 2022;29(6):966-977. doi: 10.5603/CJ.a2020.0134. Epub 2020 Nov 3.
10
Timing of hypertonic saline inhalation for cystic fibrosis.囊性纤维化患者吸入高渗盐水的时机
Cochrane Database Syst Rev. 2012 Feb 15(2):CD008816. doi: 10.1002/14651858.CD008816.pub2.

本文引用的文献

1
Efficacy of hypertonic saline versus isotonic saline among children with cystic fibrosis: A systematic review and meta-analysis.高渗盐水与等渗盐水对囊性纤维化儿童的疗效：一项系统评价与荟萃分析。
Can J Respir Ther. 2023 Jan 20;59:1-7. doi: 10.29390/cjrt-2022-046. eCollection 2023.
2
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
3
Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.预防囊性纤维化婴儿吸入高渗盐水（PRESIS）。一项随机、双盲、对照研究。
Am J Respir Crit Care Med. 2019 May 15;199(10):1238-1248. doi: 10.1164/rccm.201807-1203OC.
4
How to do a systematic review.如何进行系统评价。
Int J Stroke. 2018 Feb;13(2):138-156. doi: 10.1177/1747493017743796. Epub 2017 Nov 17.
5
Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.肺清除指数作为囊性纤维化幼儿临床试验的结局指标。一项使用吸入高渗盐水的初步研究。
Am J Respir Crit Care Med. 2013 Aug 15;188(4):456-60. doi: 10.1164/rccm.201302-0219OC.
6
Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.吸入高渗盐水在婴儿和 6 岁以下囊性纤维化儿童中的应用：ISIS 随机对照试验。
JAMA. 2012 Jun 6;307(21):2269-77. doi: 10.1001/jama.2012.5214.
7
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.Cochrane 协作网评估随机试验偏倚风险的工具。
BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928.
8
Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.高渗盐水可改善肺功能正常的 CF 患儿的 LCI。
Thorax. 2010 May;65(5):379-83. doi: 10.1136/thx.2009.125831.
9
Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.确定囊性纤维化问卷修订版呼吸症状量表在两组囊性纤维化合并慢性铜绿假单胞菌气道感染患者中的最小临床重要差异分数。
Chest. 2009 Jun;135(6):1610-1618. doi: 10.1378/chest.08-1190. Epub 2009 May 15.
10
What is "quality of evidence" and why is it important to clinicians?什么是“证据质量”，它对临床医生为何重要？
BMJ. 2008 May 3;336(7651):995-8. doi: 10.1136/bmj.39490.551019.BE.